Trinity COVID-19 Immunology Project
The Trinity COVID-19 Immunology Project builds on Trinity’s world-class Immunology expertise, accelerating research now to tackle COVID-19 and develop solutions to control the pandemic and protect our communities. The Trinity COVID-19 Immunology Project will accelerate research in these critical areas:
- Develop new antibody tests: we will develop our own new rapid assays to address the increasingly urgent problem of supply and validation of commercial antibody testing kits.
- Scale up antibody testing: we will develop, validate and deploy rapid antibody testing to identify current and previous COVID-19 infection in high-priority healthcare workers and eventually in the community to identify those who have recovered from infection and are likely to be safe to go back to work.
- Investigate immune response in COVID-19 patients:we will assess immune responses at a cellular and genomic level in infected and recovered patients to investigate whether previous infection prevents re-infection. This will provide key data for allowing antibody-positive individuals to go back to work, direct treatment options focused on suppressing inflammation in patients with most severe COVID-19, and inform vaccine design.
- Design new drugs and vaccines for COVID-19: we will investigate immunization approaches to induce ‘protective’ immune response and immunological memory which will be essential in the design of an effective vaccine and the best long-term strategy for controlling the COVID-19 pandemic.
The Trinity COVID-19 Immunology Project is led by Kingston Mills, Professor of Experimental Immunology and Director of Trinity Biomedical Sciences Institute, and Aideen Long, Professor in Molecular Medicine and Director of Trinity Translational Medicine Institute. It is a collaborative research project, led by Trinity Biomedical Sciences Institute and Trinity Translational Medicine Institute and supported by the Clinical Research Facility based on the St. James’s Hospital campus.
The Trinity COVID-19 Immunology Project will involve scientists and immunologists working on basic and applied research and infectious disease consultants, immunologists, respiratory disease physicians and intensive care specialists working with COVID-19 patients.
The Trinity COVID-19 Immunology Project is based in Trinity Biomedical Sciences Institute, Ireland’s largest biomedical research facility, which houses the AIB COVID-19 Research Laboratories Hub, and is home to the greatest critical mass of internationally recognised immunologists and scientists in Ireland, including Luke O’Neill FRS, Chair of Biochemistry and Cliona O'Farrelly, Chair in Comparative Immunology.
Trinity has the expertise and capacity allied with its national and global scientific and clinical network to accelerate Immunology research to tackle COVID-19 now and to make a real difference to the lives of many people who have or might contract COVID-19.
If you would like further information on how to support the Trinity COVID-19 Immunology Project, please contact Sonya Perkins, Associate Director, Trinity Development & Alumni email@example.com
COVID-19 Immunology Webinar
In this webinar facilitated by Bursar & Director of Strategic Innovation Professor Veronica Campbell, Kingston Mills, Aideen Long and Luke O’Neill will share their knowledge and discuss their research projects and their vision for how Trinity can leverage its expertise to control the COVID-19 epidemic in Ireland and contribute to the global effort to discover new drugs and vaccines.